{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:16Z","timestamp":1791928876338,"version":"4.3.4"},"reference-count":54,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,5,29]]},"DOI":"10.1167\/iovs.66.5.46","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:30:30Z","timestamp":1748521830000},"page":"46","source":"Crossref","is-referenced-by-count":0,"title":["Potential Application of Bendazac L-Lysine for Controlling Myopia Progression, as Demonstrated in Two Experimental Guinea Pig Myopia Models"],"prefix":"10.1167","volume":"66","author":[{"given":"Zhenqi","family":"Guan","sequence":"first","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"Jiao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengcong","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Qu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtian","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"},{"name":"State Key Laboratory of Eye Health, Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People\u2019s Republic of China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaozhen","family":"Pan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Oujiang Laboratory, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cxo.12845","article-title":"Myopia: is the nature-nurture debate finally over?","volume":"102","author":"Morgan","year":"2019","journal-title":"Clin Exp Optom"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.12.001","article-title":"Updates of pathologic myopia","volume":"52","author":"Ohno-Matsui","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/APO.0000000000000234","article-title":"Epidemiology of pathologic myopia in Asia and worldwide","volume":"5","author":"Wong","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","article-title":"Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial","volume":"314","author":"He","year":"2015","journal-title":"JAMA"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/OPX.0000000000001053","article-title":"Spherical soft contact lens designs and peripheral defocus in myopic eyes","volume":"94","author":"Moore","year":"2017","journal-title":"Optom Vis Sci"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/medicina59101859","article-title":"Preventing the progression of myopia in children-a review of the past decade","volume":"59","author":"Wnekowicz-Augustyn","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/ICU.0000000000000367","article-title":"Current approaches to myopia control","volume":"28","author":"Leo","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/APO.0000000000000617","article-title":"Low-concentration atropine eye drops for myopia progression","volume":"12","author":"Yam","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","article-title":"Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: low-concentration atropine for myopia progression study","volume":"128","author":"Li","year":"2021","journal-title":"Ophthalmology"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaophthalmol.2020.6239","article-title":"Progression of myopia in school-aged children after COVID-19 home confinement","volume":"139","author":"Wang","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"bib14","doi-asserted-by":"crossref","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","article-title":"Scleral hypoxia is a target for myopia control","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1573406414666180524082445","article-title":"Sorbinil, an aldose reductase inhibitor, in fighting against diabetic complications","volume":"15","author":"Huang","year":"2019","journal-title":"Medicinal Chemistry"},{"key":"bib16","first-page":"1073","article-title":"The role of aldose reductase in polyol pathway: an emerging pharmacological target in diabetic complications and associated morbidities","volume":"14","author":"Gupta","year":"2023","journal-title":"Curr Pharm Biotechnol"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2337\/db23-0006","article-title":"Discovery of a novel benzothiadiazine-based selective aldose reductase inhibitor as potential therapy for diabetic peripheral neuropathy","volume":"73","author":"Jin","year":"2023","journal-title":"Diabetes"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jdiacomp.2013.11.002","article-title":"Aldose reductase, glucose and cataracts","volume":"28","author":"Petrovic","year":"2014","journal-title":"J Diabetes Complications"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cbi.2011.02.023","article-title":"Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders","volume":"191","author":"Srivastava","year":"2011","journal-title":"Chem Biol Interact"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4103\/ijem.ijem_242_22","article-title":"Ranirestat improves electrophysiologic but not clinical measures of diabetic polyneuropathy: a meta-analysis","volume":"26","author":"Dutta","year":"2022","journal-title":"Indian J Endocrinol Metab"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"175191","DOI":"10.1016\/j.ejphar.2022.175191","article-title":"Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer","volume":"931","author":"Bailly","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2337\/diacare.27.2.448","article-title":"Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration","volume":"27","author":"Johnson","year":"2004","journal-title":"Diabetes Care"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/0006-2952(95)98499-Y","article-title":"Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase","volume":"49","author":"Cook","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2165\/00003495-199039040-00007","article-title":"Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts","volume":"39","author":"Balfour","year":"1990","journal-title":"Drugs"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.exer.2005.09.001","article-title":"Axial myopia induced by a monocularly-deprived facemask in guinea pigs: a non-invasive and effective model","volume":"82","author":"Lu","year":"2006","journal-title":"Exp Eye Res"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.exer.2009.02.019","article-title":"Axial myopia induced by hyperopic defocus in guinea pigs: a detailed assessment on susceptibility and recovery","volume":"89","author":"Lu","year":"2009","journal-title":"Exp Eye Res"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1210\/er.2004-0028","article-title":"Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options","volume":"26","author":"Srivastava","year":"2005","journal-title":"Endocr Rev"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1172\/JCI4711","article-title":"Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis","volume":"103","author":"Rittner","year":"1999","journal-title":"J Clin Invest"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1159\/000438521","article-title":"Zopolrestat induced suicidal death of human erythrocytes","volume":"37","author":"Bouguerra","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"7887","DOI":"10.1167\/iovs.13-11999","article-title":"The role of cGMP in ocular growth and the development of form-deprivation myopia in guinea pigs","volume":"54","author":"Fang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1167\/iovs.17-22297","article-title":"Opposing effects of PPARalpha agonism and antagonism on refractive development and form deprivation myopia in guinea pigs","volume":"59","author":"Pan","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1167\/iovs.08-2463","article-title":"Spontaneous axial myopia and emmetropization in a strain of wild-type guinea pig (Cavia porcellus)","volume":"50","author":"Jiang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1167\/iovs.13-12361","article-title":"Daily injection but not continuous infusion of apomorphine inhibits form-deprivation myopia in mice","volume":"56","author":"Yan","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/j.visres.2006.01.027","article-title":"Normal development of refractive state and ocular dimensions in guinea pigs","volume":"46","author":"Zhou","year":"2006","journal-title":"Vision Res"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1167\/iovs.18-26397","article-title":"Changes in choroidal thickness and choroidal blood perfusion in guinea pig myopia","volume":"60","author":"Zhang","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF00165675","article-title":"The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy","volume":"78","author":"Tromp","year":"1991","journal-title":"Doc Ophthalmol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bjo.2004.049841","article-title":"A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients","volume":"89","author":"Nakahara","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1043-6618(05)80042-8","article-title":"Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent","volume":"32","author":"Guglielmotti","year":"1995","journal-title":"Pharmacol Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1208\/s12248-008-9024-9","article-title":"Topical ocular delivery of NSAIDs","volume":"10","author":"Ahuja","year":"2008","journal-title":"The AAPS J"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1034\/j.1600-0420.2000.078005495.x","article-title":"Effects of prostaglandins on form deprivation myopia in the chick","volume":"78","author":"Jin","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.drudis.2014.10.007","article-title":"Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives","volume":"20","author":"Lv","year":"2015","journal-title":"Drug Discov Today"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.62.15.30","article-title":"Decreased choroidal blood perfusion induces myopia in guinea pigs","volume":"62","author":"Zhou","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.14773","article-title":"The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow","volume":"99","author":"Liu","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.exer.2013.03.008","article-title":"The choroid as a sclera growth regulator","volume":"114","author":"Summers","year":"2013","journal-title":"Exp Eye Res"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/APO.0000000000000233","article-title":"Environmental factors and myopia: paradoxes and prospects for prevention","volume":"5","author":"Rose","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.47102\/annals-acadmedsg.V33N1p34","article-title":"The epidemiology of myopia in Hong Kong","volume":"33","author":"Edwards","year":"2004","journal-title":"Ann Acad Med Singap"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ophtha.2024.03.013","article-title":"Five-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 4 report","volume":"131","author":"Zhang","year":"2024","journal-title":"Ophthalmology"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ajo.2015.01.029","article-title":"Risk factors for progressive myopia in the atropine therapy for myopia study","volume":"159","author":"Loh","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF02764301","article-title":"Medical treatment of senile cataract: clinical investigation of bendazac-lysine using objective and subjective methods","volume":"228","author":"Baraldi","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:06Z","timestamp":1791927126000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.5.46","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}